Enzon Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.13 |
Market Cap |
$11.5 M |
Shares Outstanding |
44.22 M |
Public Float |
37.52 M |
Enzon Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
44.21 M |
Public Float |
34.24 M |
Address |
20 Commerce Drive Cranford New Jersey 07016 United States |
Employees | - |
Website | http://www.enzon.com |
Updated | 07/08/2019 |
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ. . |